Abstract
Gal-3 (formerly known as CBP35, Mac2, L-29, L-34, IgEBP, and LBP) is widely spread among different types of cells and tissues, found intracellularly in nucleus and cytoplasm or secreted via non-classical pathway out of cell, thus being found on the cell surface or in the extracellular space. Through specific interactions with a variety of intra- and extracellular proteins Gal-3 affects numerous biological processes and seems to be involved in different physiological and pathophysiological conditions, such as development, immune reactions, and neoplastic transformation and metastasis. Most members of the galectin family including Gal-1 possess apoptotic activities, whereas Gal-3 possesses anti-apoptotic activity as well. Information on structural, biochemical and intriguing functional properties of Gal-3 have been reviewed extensively (Dumic et al. 2006).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ahmad N, Gabius HJ, Andre S et al (2004a) Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes. J Biol Chem 279:10841–10847
Ahmad N, Gabius HJ, Sabesan S et al (2004b) Thermodynamic binding studies of bivalent oligosaccharides to Gal-1, galectin-3, and the carbohydrate recognition domain of galectin-3. Glycobiology 14:817–825
Ahmed H, Du S-J, O’Leary N, Vasta GR (2004) Biochemical and molecular characterization of galectins from zebrafish (Danio rerio): notochord-specific expression of a prototype galectin during early embryogenesis. Glycobiology 14:219–232
Akahani S, Nangia-Makker P, Inohara H et al (1997) Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res 57:5272–5276
Almkvist J, Dahlgren C, Leffler H, Karlsson A (2004) Newcastle disease virus neuraminidase primes neutrophils for stimulation by galectin-3 and formyl-Met-Leu-Phe. Exp Cell Res 298:74–82
Arata Y, Tamura M, Nonaka T, Kasai K (2006) Crosslinking of low-affinity glycoprotein ligands to galectin LEC-1 using a photoactivatable sulfhydryl reagent. Biochem Biophys Res Commun 350:185–190
Barboni E, Coade S, Fiori A (2005) The binding of mycolic acids to galectin-3: a novel interaction between a host soluble lectin and trafficking mycobacterial lipids? FEBS Lett 579:6749–6755
Bawumia S, Barboni EAM, Menon RP, Hughes RC (2003) Specificity of interactions of galectin-3 with Chrp, a cysteine- and histidine-rich cytoplasmic protein. Biochimie 85:189–194
Beatty WL, Rhoades ER, Hsu DK et al (2002) Association of a macrophage galactoside-binding protein with Mycobacterium-containing phagosomes. Cell Microbiol 4:167–176
Bernardes ES, Silva NM, Ruas LP et al (2006) Toxoplasma gondii infection reveals a novel regulatory role for galectin-3 in the interface of innate and adaptive immunity. Am J Pathol 168:1910–1920
Bichara M, Attmane-Elakeb A, Brown D et al (2006) Exploring the role of galectin 3 in kidney function: a genetic approach. Glycobiology 16:36–45
Bickle Q, Helmby H (2007) Lack of galectin-3 involvement in murine intestinal nematode and schistosome infection. Parasite Immunol 29:93–100
Birdsall B, Feeney J, Burdett IDJ et al (2001) NMR solution studies of hamster galectin-3 and electron microscopic visualization of surface-adsorbed complexes: evidence for interactions between the N- and C-terminal domains. Biochemistry 40:4859–4866
Bresalier RS, Mazurek N, Sternberg LR et al (1998) Metastasis of human colon cancer is altered by modifying expression of the β-galactoside-binding protein galectin 3. Gastroenterology 115:287–296
Bresalier RS, Byrd JC, Tessler D, Lebel J, Koomen J, Hawke D, Half E, Liu KF (2004) A circulating ligand for galectin-3 is a haptoglobin-related glycoprotein elevated in individuals with colon cancer. Gastroenterology 127:741–748
Breuilh L, Vanhoutte F, Fontaine J et al (2007) Galectin-3 modulates immune and inflammatory responses during helminthic infection: impact of galectin-3 deficiency on the functions of dendritic cells. Infect Immun 75:5148–5157
Brewer CF, Miceli MC, Baum LG (2002) Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions. Curr Opin Struct Biol 12:616–623
Cao Z, Said N, Amin S et al (2002a) Galectins-3 and -7, but not Gal-1, play a role in re-epithelialization of wounds. J Biol Chem 277:42299–42305
Cao Z, Wu HK, Bruce A et al (2002b) Detection of differentially expressed genes in healing mouse corneas, using cDNA microarrays. Invest Ophthalmol Vis Sci 43:2897–2904
Cecchinelli B, Lavra L, Rinaldo C et al (2006) Repression of the antiapoptotic molecule galectin-3 by homeodomain-interacting protein kinase 2-activated p53 is required for p53-induced apoptosis. Mol Cell Biol 26:4746–4757
Chen H-Y, Fermin A, Vardhana S et al (2009) Galectin-3 negatively regulates TCR-mediated CD4+ T-cell activation at the immunological synapse. Proc Natl Acad Sci USA 106:14496–14501
Chen HY, Liu FT, Yang RY (2005) Roles of galectin-3 in immune responses. Arch Immunol Ther Exp (Warsz) 53:497–504
Chen HY, Sharma BB, Yu L et al (2006) Role of galectin-3 in mast cell functions: galectin-3-deficient mast cells exhibit impaired mediator release and defective JNK expression. J Immunol 177:4991–4997
Chiu MG, Johnson TM, Woolf AS (2006) Galectin-3 associates with the primary cilium and modulates cyst growth in congenital polycystic kidney disease. Am J Pathol 169:1925–1938
Collins PM, Hidari KI, Blanchard H (2007) Slow diffusion of lactose out of galectin-3 crystals monitored by x-ray crystallography: possible implications for ligand-exchange protocols. Acta Crystallogr D Biol Crystallogr 63:415–419
Dabelic S, Supraha S, Dumic J (2006) Galectin-3 in macrophage-like cells exposed to immunomodulatory drugs. Biochim Biophys Acta 1760:701–709
David A, Kopeckova P, Minko T et al (2004) Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells. Eur J Cancer 40:148–157
Davidson PJ, Li SY, Lohse AG et al (2006) Transport of galectin-3 between the nucleus and cytoplasm. I. Conditions and signals for nuclear import. Glycobiology 16:602–611
Delacour D, Cramm-Behrens CI, Drobecq H et al (2006) Requirement for galectin-3 in apical protein sorting. Curr Biol 16:408–414
Demetriou M, Granovsky M, Quaggin S, Dennis JW (2001) Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409:733–739
Deschildre C, Ji JW, Chater S et al (2007) Expression of galectin-3 and its regulation in the testes. Int J Androl 30:28–40
Devouassoux-Shisheboran M, Deschildre C et al (2006) Expression of galectin-3 in gonads and gonadal sex cord stromal and germ cell tumors. Oncol Rep 16:335–340
Dong S, Hughes RC (1997) Macrophage surface glycoproteins binding to galectin-3 (Mac-2-antigen). Glycoconj J 14:267–274
Dumic J, Dabelic S, Flogel M (2006) Galectin-3: an open-ended story. Biochim Biophys Acta 1760:616–635
Duneau M, Boyer-Guittaut M, Gonzalez P et al (2005) Galig, a novel cell death gene that encodes a mitochondrial protein promoting cytochrome c release. Exp Cell Res 302:194–205
Farnworth SL, Henderson NC, MacKinnon AC et al (2008) Galectin-3 reduces the severity of pneumococcal pneumonia by augmenting neutrophil function. Am J Pathol 172:395–405
Fernandez GC, Ilarregui JM, Rubel CJ et al (2005) Galectin-3 and soluble fibrinogen act in concert to modulate neutrophil activation and survival: involvement of alternative MAPK pathways. Glycobiology 15:519–527
Feuk-Lagerstedt E, Jordan ET, Leffler H, Dahlgren C, Karlsson A (1999) Identification of CD66a and CD66b as the major galectin-3 receptor candidates in human neutrophils. J Immunol 163:5592–5598
Forsman H, Islander U, Andréasson E et al (2011) Galectin 3 aggravates joint inflammation and destruction in antigen-induced arthritis. Arthritis Rheum 63:445–454
Fowler M, Thomas RJ, Atherton J, Roberts IS, High NJ (2006) Galectin-3 binds to Helicobacter pylori O-antigen: it is upregulated and rapidly secreted by gastric epithelial cells in response to H. pylori adhesion. Cell Microbiol 8:44–54
Fradin C, Poulain D, Jouault T (2000) β-1,2-linked oligomannosides from Candida albicans bind to a 32 kilodalton macrophage membrane protein homologous to the mammalian lectin galectin-3. Infect Immun 68:4391–4398
Friedrichs J, Manninen A, Muller DJ, Helenius J (2008) Galectin-3 regulates integrin _α2β1-mediated adhesion to collagen-I and -IV. J Biol Chem 283:32264–32272
Frigeri LG, Zuberi RI, Liu FT (1993) Epsilon BP, a beta-galactoside-binding animal lectin, recognizes IgE receptor (Fc epsilon RI) and activates mast cells. Biochemistry 32:7644–7649
Fukumori T, Kanayama HO, Raz A (2007) The role of galectin-3 in cancer drug resistance. Drug Resist Update 10:101–108
Fukumori T, Takenaka Y, Oka N et al (2004) Endogenous galectin-3 determines the routing of CD95 apoptotic signaling pathways. Cancer Res 64:3376–3379
Fukumori T, Takenaka Y, Yoshii T et al (2003) CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis. Cancer Res 63:8302–8311
Fukushi J, Makagiansar IT, Stallcup WB (2004) NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and α3β1 integrin. Mol Biol Cell 15:3580–3590
Gebhardt A, Ackermann W, Unver N, Elsässer H-P. Expression of galectin-3 in the rat pancreas during regeneration following hormone-induced pancreatitis. Cell Tissue Res 2004; 315:321–9
Ghanooni R, Decaestecker C, Simon P et al (2006) Characterization of patterns of expression of protein kinase C- α, -δ, -η, -γ and -ζ and their correlations to p53, galectin-3, the retinoic acid receptor-β and the macrophage migration inhibitory factor (MIF) in human cholesteatomas. Hear Res 214:7–16
Gil CD, La M, Perretti M, Oliani SM (2006) Interaction of human neutrophils with endothelial cells regulates the expression of endogenous proteins annexin 1, Gal-1 and galectin-3. Cell Biol Int 30:338–344
Goletz S, Hanisch F-G, Karsten U (1997) Novel αGalNAc containing glycans on cytokeratins are recognized in vitro by galectins with type II carbohydrate recognition domains. J Cell Sci 110:1585–1596
Gonen T, Grey AC, Jacobs MD, Donaldson PJ, Kistler J (2001) MP20, the second most abundant lens membrane protein and member of the tetraspanin superfamily, joins the list of ligands of galectin-3. BMC Cell Biol 2:17
Guevremont M, Martel-Pelletier J, Boileau C et al (2004) Galectin-3 surface expression on human adult chondrocytes: a potential substratem for collagenase-3. Ann Rheum Dis 63:636–643
Gupta SK, Masinick S, Garrett M, Hazlett LD (1997) Pseudomonas aeruginosa lipopolysaccharide binds galectin-3 and other human corneal epithelial proteins. Infect Immun 65:2747–2753
Henderson NC, Mackinnon AC, Farnworth SL et al (2006) Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci USA 103:5060–5065
Henrick K, Bawumia S, Barboni EAM et al (1998) Evidence for subsites in the galectins involved in sugar binding at the nonreducing end of the central galactose of oligosaccharide ligands: sequence analysis, homology modeling and mutagenesis studies of hamster galectin-3. Glycobiology 8:45–57
Hirabayashi J, Hashidate T, Arata Y et al (2002) Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochim Biophys Acta 1572:232–254
Hsu DK, Chen HY, Liu FT (2009) Galectin-3 regulates T-cell functions. Immunol Rev 230:114–127
Hsu DK, Yang RY, Pan Z et al (2000) Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am J Pathol 156:1073–1083
Hudkins KL, Pichaiwong W, Wietecha T et al (2010) BTBR Ob/Ob mutant mice model progressive diabetic nephropathy. J Am Soc Nephrol 21:1533–1542
Huflejt ME, Turck CW, Lindstedt R et al (1993) L-29, a soluble lactose-binding lectin, is phosphorylated on serine 6 and serine 12 in vivo and by casein kinase I. J Biol Chem 268:26712–26718
Hughes RC (2001) Galectins as modulators of cell adhesion. Biochimie 83:667–676
Hughes RC (1994) Mac-2: a versatile galactose-binding protein of mammalian tissues. Glycobiology 4:5–12
Hughes RC (1999) Secretion of the galectin family of mammalian carbohydrate binding proteins. Biochim Biophys Acta 1473:172–185
Hughes RC (1997) The galectin family of mammalian carbohydrate-binding molecules. Biochem Soc Trans 25:1194–1198
Iacobini C, Amadio L, Oddi G et al (2003) Role of galectin-3 in diabetic nephropathy. J Am Soc Nephrol 14:S264–S270
Iacobini C, Menini S, Oddi G et al (2004) Galectin-3/AGE-receptor 3 knockout mice show accelerated AGE-induced glomerular injury: evidence for a protective role of galectin-3 as an AGE receptor. FASEB J 18:1773–1775
Iacobini C, Menini S, Ricci C et al (2009a) Accelerated lipid-induced atherogenesis in galectin-3-deficient mice: role of lipoxidation via receptor-mediated mechanisms. Arterioscler Thromb Vasc Biol 29:831–836
Iacobini C, Menini S, Ricci C et al (2009b) Advanced lipoxidation end-products mediate lipid-induced glomerular injury: role of receptor-mediated mechanisms. J Pathol 218:360–369
Iacobini C, Oddi G, Menini S et al (2005) Development of age-dependent glomerular lesions in galectin-3/AGE-receptor-3 knockout mice. Am J Physiol Renal Physiol 289:F611–F621
Iacovazzi PA, Notarnicola M, Caruso MG et al (2010) Serum levels of galectin-3 and its ligand 90 k/mac-2 bp in colorectal cancer patients. Immunopharmacol Immunotoxicol 32:160–164
Inohara H, Raz A (1994) Identification of human melanoma cellular and secreted ligands for galectin-3. Biochem Biophys Res Commun 201:1366–1375
Janeway CA Jr, Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20:197–216
Jawhara S, Thuru X, Standaert-Vitse A et al (2008) Colonization of mice by Candida albicans is promoted by chemically induced colitis and augments inflammatory responses through galectin-3. J Infect Dis 197:972–980
Jeon SB, Yoon HJ, Chang CY et al (2010) Galectin-3 exerts cytokine-like regulatory actions through the JAK-STAT pathway. J Immunol 185:7037–7046
Jiang HR, Al Rasebi Z, Mensah-Brown E et al (2009) Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis. J Immunol 182:1167–1173
Jin R, Greenwald A, Peterson MD, Waddell TK (2006) Human monocytes recognize porcine endothelium via the interaction of galectin 3 and α-GAL. J Immunol 177:1289–1295
Johnson KD, Glinskii OV, Mossine VV et al (2007) Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelia. Neoplasia 9:662–670
Joo HG, Goedegebuure PS, Sadanaga N et al (2001) Expression and function of galectin-3, a beta-galactoside-binding protein in activated T lymphocytes. J Leukoc Biol 69:555–564
Jouault T, El Abed-El Behi M, Martinez-Esparza M et al (2006) Specific recognition of Candida albicans by macrophages requires galectin-3 to discriminate Saccharomyces cerevisiae and needs association with TLR2 for signaling. J Immunol 177:4679–4687
Kadrofske MM, Openo KP, Wang JL (1998) The human LGALS3 (galectin-3) gene: determination of the gene structure and functional characterization of the promoter. Arch Biochem Biophys 349:7–20
Kaji Y (2005) Expression and function of receptors for advanced glycation end products in bovine corneal endothelial cells. Nippon Ganka Gakkai Zasshi 109:691–699, Abstract
Karlsen AE, Storling ZM, Sparre T et al (2006) Immune-mediated β-cell destruction in vitro and in vivo-A pivotal role for galectin-3. Biochem Biophys Res Commun 344:406–415
Karlsson A, Christenson K, Matlak M, Björstad A, Brown KL, Telemo E, Salomonsson E, Leffler H, Bylund J (2009) Galectin-3 functions as an opsonin and enhances the macrophage clearance of apoptotic neutrophils. Glycobiology 19:16–20
Khoo KH, Dell A (2001) Glycoconjugates from parasitic helminths: structure diversity and immunobiological implications. Adv Exp Med Biol 491:185–205
Kim H, Kang TY, Joo HG, Shin T (2006) Immunohistochemical localization of galectin-3 in boar testis and epididymis. Acta Histochem 108:481–485
Kim HR, Lin HM, Biliran H, Raz A (1999) Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells. Cancer Res 59:4148–4154
Kiwaki K, Novak CM, Hsu DK, Liu FT, Levine JA (2007) Galectin-3 stimulates preadipocyte proliferation and is up-regulated in growing adipose tissue. Obesity (Silver Spring) 15:32–39
Kleshchenko YY, Moody TN, Furtak VA et al (2004) Human galectin-3 promotes Trypanosoma cruzi adhesion to human coronary artery smooth muscle cells. Infect Immun 72:6717–6721
Kohatsu L, Hsu DK, Jegalian AG et al (2006) Galectin-3 induces death of Candida species expressing specific β-1,2-linked mannans. J Immunol 177:4718–4726
Koths K, Taylor E, Halenbeck R et al (1993) Cloning and characterization of a human Mac-2-binding protein, a new member of the superfamily defined by the macrophage scavenger receptor cysteine-rich domain. J Biol Chem 268:14245–14249
Krześlak A, Lipińska A (2004) Galectin-3 as a multifunctional protein. Cell Mol Biol Lett 9:305–328
Kuwabara I, Liu FT (1996) Galectin-3 promotes adhesion of human neutrophils to laminin. J Immunol 156:3939–3944
Lacina L, Plzakova Z, Smetana K Jr et al (2006) Glycophenotype of psoriatic skin. Folia Biol (Praha) 52:10–15
Li L, Liu CT, Wang K, Pang YM (2005) Inhibitory effects of galectin-3 on the inflammatory cytokines and chemokines in guinea pig asthma models. Sichuan Da Xue Xue Bao Yi Xue Ban 36:355–358
Li SY, Davidson PJ, Lin NY et al (2006) Transport of galectin-3 between the nucleus and cytoplasm II. Identification of the signal for nuclear export. Glycobiology 16:612–622
Li Y, Komai-Koma M, Gilchrist DS et al (2008) Galectin-3 is a negative regulator of lipopolysaccharide-mediated inflammation. J Immunol 181:2781–2789
Li YJ, Kukita A, Teramachi J et al (2009) A possible suppressive role of galectin-3 in upregulated osteoclastogenesis accompanying adjuvant-induced arthritis in rats. Lab Invest 89:26–37
Liao DI, Kapadia G, Ahmed H, Vasta GR, Herzberg O (1994) Structure of S-lectin, a developmentally regulated vertebrate β-galactoside-binding protein. Proc Natl Acad Sci USA 91:1428–1432
Liew FY, Xu D, Brint EK, O’Neill LA (2005) Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 5:446–458
Lin H-M, Moon B-K, Yu F, Kim H-RC (2000) Galectin-3 mediates genistein–induced G2/M arrest and inhibits apoptosis. Carcinogenesis 21:1941–1945
Lin H-M, Pestell RG, Raz A, Kim H-RC (2002) Galectin-3 enhances cyclin D1 promoter activity through SP1 and a cAMP-responsive element in human breast epithelial cells. Oncogene 21:8001–8010
Lippert E, Falk W, Bataille F et al (2007) Soluble galectin-3 is a strong, colonic epithelial-cell-derived, lamina propria fibroblast-stimulating factor. Gut 56:43–51
Liu F-T, Patterson RJ, Wang JL (2002) Intracellular functions of galectins. Biochim Biophys Acta 1572:263–273
Liu F-T, Rabinovich GA (2005) Galectins as modulators of tumour progression. Nat Rev Cancer 5:29–41
Liu F-T (2005) Regulatory roles of galectins in the immune response. Int Arch Allergy Immunol 136:385–400
Liu L, Sakai T, Sano N, Fukui K (2004) Nucling mediates apoptosis by inhibiting expression of galectin-3 through interference with nuclear factor kappaB signalling. Biochem J 380:31–41
Lobsanov YD, Gitt MA, Leffler H et al (1993) Xray crystal structure of the human dimeric s-Lac lectin, L-14-II, in complex with lactose at 2.9 Å resolution. J Biol Chem 268:27034–27038
Lohr M, Kaltner H, Lensch M et al (2008) Cell-type-specific expression of murine multifunctional galectin-3 and its association with follicular atresia/luteolysis in contrast to pro-apoptotic galectins-1 and -7. Histochem Cell Biol 130:567–581
Lopez E, del Pozo V, Miguel T et al (2006) Inhibition of chronic airway inflammation and remodeling by galectin-3 gene therapy in a murine model. J Immunol 176:1943–1950
Lukyanov P, Furtak V, Ochieng J (2005) Galectin-3 interacts with membrane lipids and penetrates the lipid bilayer. Biochem Biophys Res Commun 338:1031–1036
MacKinnon AC, Farnworth SL, Hodkinson PS et al (2008) Regulation of alternative macrophage activation by galectin-3. J Immunol 180:2650–2658
Mandrell RE, Apicella MA, Lindstedt R, Leffler H (1994) Possible interaction between animal lectins and bacterial carbohydrates. Methods Enzymol 236:231–254
Matarrese P, Fusco O, Tinari N et al (2000) Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Int J Cancer 85:545–554
Mazurek N, Conklin J, Byrd JC et al (2000) Phosphorylation of the β-galactoside-binding protein galectin-3 modulates binding to its ligands. J Biol Chem 275:36311–36315
McFarlane S, Glenn JV, Lichanska AM et al (2005) Characterisation of the advanced glycation endproduct receptor complex in the retinal pigment epithelium. Br J Ophthalmol 89:107–112
Menon RP, Hughes RC (1999) Determinants in the N-terminal domains of galectin-3 for secretion by a novel pathway circumventing the endoplasmic reticulum–golgi complex. Eur J Biochem 264:569–576
Menon RP, Strom M, Hughes RC (2000) Interaction of a novel cysteine and histidine-rich cytoplasmic protein with galectin-3 in a carbohydrateindependent manner. FEBS Lett 470:227–231
Mensah-Brown E, Shahin A, Parekh K et al (2006) Functional capacity of macrophages determines the induction of type 1 diabetes. Ann N Y Acad Sci 1084:49–57
Mensah-Brown EP, Al Rabesi Z, Shahin A et al (2009) Targeted disruption of the galectin-3 gene results in decreased susceptibility to multiple low dose streptozotocin-induced diabetes in mice. Clin Immunol 130:83–88
Mercer N, Ahmed H et al (2004) AGE-R3/galectin-3 expression in osteoblast-like cells: regulation by AGEs. Mol Cell Biochem 266:17–24
Mey A, Leffler H, Hmama Z et al (1996) The animal lectin galectin-3 interacts with bacterial lipopolysaccharides via two independent sites. J Immunol 156:1572–1577
Miller SI, Ernst RK, Bader MW (2005) LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol 3:36–46
Mina-Osorio P, Soto-Cruz I, Ortega E (2007) A role for galectin-3 in CD13-mediated homotypic aggregation of monocytes. Biochem Biophys Res Commun 353:605–610
Mok SW, Riemer C, Madela K et al (2007) Role of galectin-3 in prion infections of the CNS. Biochem Biophys Res Commun 359:672–678
Moon B-K, Lee YJ, Battle P et al (2001) Galectin-3 protects human breast carcinoma cells against nitric oxideinduced apoptosis. Implication of galectin-3 function during metastasis. Am J Pathol 159:1055–1060
Morgan R, Gao G, Pawling J et al (2004) N-acetylglucosaminyltransferase V (Mgat5)-mediated N-glycosylation negatively regulates Th1 cytokine production by T cells. J Immunol 173:7200–7208
Muller S, Schaffer T, Flogerzi B et al (2006) Galectin-3 modulates T cell activity and is reduced in the inflamed intestinal epithelium in IBD. Inflamm Bowel Dis 12:588–597
Nachtigal M, Ghaffar A, Mayer EP (2008) Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice. Am J Pathol 172:247–255
Nagata S (2000) Apoptosis. Fibrinol Proteol 14:82–86
Nakahara S, Hogan V, Inohara H, Raz A (2006a) Importin-mediated nuclear translocation of galectin-3. J Biol Chem 281:39649–39659
Nakahara S, Oka N, Raz A (2005) On the role of galectin-3 in cancer apoptosis. Apoptosis 10:267–275
Nakahara S, Oka N, Wang Y et al (2006b) Characterization of the nuclear import pathways of galectin-3. Cancer Res 66:9995–10006
Narciso MS, Mietto Bde S, Marques SA et al (2009) Sciatic nerve regeneration is accelerated in galectin-3 knockout mice. Exp Neurol 217:7–15
Neidhart M, Zaucke F, von Knoch R et al (2005) Galectin-3 is induced in rheumatoid arthritis synovial fibroblasts after adhesion to cartilage oligomeric matrix protein. Ann Rheum Dis 64:419–424
Nickel W (2003) The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur J Biochem 270:2109–2119
Nieminen J, Kuno A, Hirabayashi J, Sato S (2007) Visualization of galectin-3 oligomerization on the surface of neutrophils and endothelial cells using fluorescence resonance energy transfer. J Biol Chem 282:1374–1383
Nieminen J, St Pierre C, Sato S (2005) Galectin-3 interacts with naive and primed neutrophils, inducing innate immune responses. J Leukoc Biol 78:1127–1135
Nieminen J, St-Pierre C, Bhaumik P et al (2008) Role of galectin-3 in leukocyte recruitment in a murine model of lung infection by Streptococcus pneumoniae. J Immunol 180:2466–2473
Nio J, Iwanaga T (2007) Galectins in the mouse ovary: concomitant expression of galectin-3 and progesterone degradation enzyme (20αHSD) in the corpus luteum. J Histochem Cytochem 55:423–432
Nio J, Takahashi-Iwanaga H, Morimatsu M, Kon Y, Iwanaga T (2006) Immunohistochemical and in situ hybridization analysis of galectin-3, a β-galactoside binding lectin, in the urinary system of adult mice. Histochem Cell Biol 126:45–56
Nomoto K, Tsuneyama K, Abdel Aziz HO (2006) Disrupted galectin-3 causes non-alcoholic fatty liver disease in male mice. J Pathol 210:469–477
Ochieng J, Furtak V, Lukyanov P (2004) Extracellular functions of galectin-3. Glycoconj J 19:527–535
Ochieng J, Leite-Browning ML, Warfield P (1998) Regulation of cellular adhesion to extracellular matrix proteins by galectin-3. Biochem Biophys Res Commun 246:788–791
Ochieng J, Warfield P, Green-Jarvis B, Fentie I (1999) Galectin-3 regulates the adhesive interaction between breast carcinoma cells and elastin. J Cell Biochem 75:505–514
Ochieng J, Warfield P (1995) Galectin-3 binding potentials of mouse tumor RHS and human placental laminins. Biochem Biophys Res Commun 217:402–406
Ocklenburg F, Moharregh-Khiabani D, Geffers R et al (2006) UBD, a downstream element of FOXP3, allows the identification of LGALS3, a new marker of human regulatory T cells. Lab Invest 86:724–737
Oda Y, Herrmann J, Gitt MA et al (1993) Soluble lactose-binding lectin from rat intestine with two different carbohydrate-binding domains in the same peptide chain. J Biol Chem 268:5929–5939
Oguz E, Tsai TT, Di Martino A et al (2007) Galectin-3 expression in the intervertebral disc: a useful marker of the notochord phenotype? Spine 32:9–16
Ohannesian DW, Lotan D, Thoman P et al (1995) Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells. Cancer Res 55:2191–2199
Okamura DM, Pasichnyk K, Lopez-Guisa JM et al (2010) Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosis. Am J Physiol Renal Physiol 300:F245–F253
Oliveira FL, Chammas R, Ricon L et al (2009) Galectin-3 regulates peritoneal B1-cell differentiation into plasma cells. Glycobiology 19:1248–1258
Oliveira FL, Frazao P, Chammas R et al (2007) Kinetics of mobilization and differentiation of lymphohematopoietic cells during experimental murine schistosomiasis in galectin-3−/− mice. J Leukoc Biol 82:300–310
Ortega N, Behonick DJ, Colnot C et al (2005) Galectin-3 is a downstream regulator of matrix metalloproteinase-9 function during endochondral bone formation. Mol Biol Cell 16:3028–3039
Pace K, Lee C, Stewart PL, Baum LG (1999) Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1. J Immunol 163:3801–3811
Park JW, Voss PG, Grabski S et al (2001) Association of Gal-1 and galectin-3 with Gemin4 in complexes containing the SMN protein. Nucl Acids Res 27:3595–3602
Patnaik SK, Potvin B, Carlsson S et al (2006) Complex N-glycans are the major ligands for Gal-1, -3, and -8 on Chinese hamster ovary cells. Glycobiology 16:305–317
Pelletier I, Sato S (2002) Specific recognition and cleavage of galectin-3 by Leishmania major through species-specific polygalactose epitope. J Biol Chem 277:17663–17670
Pilette C, Colinet B, Kiss R et al (2007) Increased galectin-3 expression and intraepithelial neutrophils in small airways in severe chronic obstructive pulmonary disease. Eur Respir J 29:914
Pricci F, Leto G, Amadio L et al (2000) Role of galectin 3 as a receptor for advanced glycosylation end products. Kidney Int 58:S31–S39
Probstmeier R, Montag D, Schachner M (1995) Galectin-3, a β- galactoside-binding animal lectin, binds to neural recognition molecules. J Neurochem 64:2465–2472
Pugliese G, Pricci F, Iacobini C et al (2001) Accelerated diabetic glomerulopathy in galectin-3/AGE receptor 3 knockout mice. FASEB J 15:2471–2479
Rabinovich GA, Baum LG et al (2002) Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? Trends Immunol 23:313–320
Rosenberg I, Cherayil BJ et al (1991) Mac-2-binding glycoproteins. Putative ligands for a cytosolic β-galactoside lectin. J Biol Chem 266:18731–18736
Rosenberg IM, Iyer R, Cherayil B, Chiodino C, Pillai S (1993) Structure of the murine Mac-2 gene. Splice variants encode proteins lacking functional signal peptides. J Biol Chem 268:12393–12400
Rousseau C, Muriel M-P, Musset M, Botti J, Sève A-P (2000) Glycosylated nuclear lectin CBP70 also associated with endoplasmic reticulum and the golgi apparatus: does the “classic pathway” of glycosylation also apply to nuclear glycoproteins? J Cell Biochem 78:638–649
Saegusa J, Hsu DK, Chen H-Y et al (2009) Galectin-3 is critical for the development of the allergic inflammatory response in a mouse model of atopic dermatitis. Am J Pathol 174:922–931
Saegusa J, Hsu DK, Liu W et al (2008) Galectin-3 protects keratinocytes from UVB-induced apoptosis by enhancing AKT activation and suppressing ERK activation. J Invest Dermatol 128:2403–2411
Sano H, Hsu DK, Apgar JR et al (2003) Critical role of galectin-3 in phagocytosis by macrophages. J Clin Invest 112:389–397
Sano H, Hsu DK, Yu L et al (2000) Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J Immunol 165:2156–2164
Sarafian V, Jadot M et al (1998) Expression of Lamp-1 and Lamp-2 and their interactions with galectin-3 in human tumor cells. Int J Cancer 75:105–111
Sato S, Burdett I, Hughes RC (1993) Secretion of the baby hamster kidney 30-kDa galactose-binding lectin from polarized and nonpolarized cells: a pathway independent of the endoplasmic reticulum-golgi complex. Exp Cell Res 207:8–18
Sato S, Hughes RC (1992) Binding specificity of a baby hamster kidney lectin for H type I and II chains, polylactosamine glycans, and appropriately glycosylated forms of laminin and fibronectin. J Biol Chem 267:6983–6990
Sato S, Nieminen J (2004) Seeing strangers or announcing “danger”: galectin-3 in two models of innate immunity. Glycoconj J 19:583–591
Sato S, Ouellet N, Pelletier I et al (2002) Role of galectin-3 as an adhesion molecule for neutrophil extravasation during Streptococcal pneumonia. J Immunol 168:1813–1822
Schwaderer AL, Vijayakumar S, Al-Awqati Q, Schwartz GJ (2006) Galectin-3 expression is induced in renal β-intercalated cells during metabolic acidosis. Am J Physiol Renal Physiol 290:F148–F158
Seetharaman J, Kanigsberg A, Slaaby R et al (1998) X-ray crystal structure of the human galectin-3 carbohydrate recognition domain at 2.1-Å resolution. J Biol Chem 273:13047–13052
Sève A-P, Felin M et al (1993) Evidence for a lactose-mediated association between two nuclear carbohydrate-binding proteins. Glycobiology 3:23–30
Sharma UC, Pokharel S, van Brakel TJ et al (2004) Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation 110:3121–3128
Shimura T, Takenaka Y, Fukumori T et al (2005) Implication of galectin-3 in Wnt signaling. Cancer Res 65:3535–3537
Shimura T, Takenaka Y, Tsutsumi S et al (2004) Galectin-3, a novel binding partner of β-catenin. Cancer Res 64:6363–6367
Shoji H, Ikenaka K, Nakakita S et al (2005) Xenopus galectin-VIIa binds N-glycans of members of the cortical granule lectin family (xCGL and xCGL2). Glycobiology 15:709–720
Shou J, Bull CM, Li L et al (2006) Identification of blood biomarkers of rheumatoid arthritis by transcript profiling of peripheral blood mononuclear cells from the rat collagen-induced arthritis model. Arthritis Res Ther 8:R28
Silva-Monteiro E, Reis Lorenzato L, Kenji Nihei O et al (2007) Altered expression of galectin-3 induces cortical thymocyte depletion and premature exit of immature thymocytes during Trypanosoma cruzi infection. Am J Pathol 170:546–556
Srivatsan J, Smith DF, Cummings RD (1992) Schistosoma mansoni synthesizes novel biantennary Asn-linked oligosaccharides containing terminal beta-linked N-acetylgalactosamine. Glycobiology 2:445–452
Stillman BN, Hsu DK et al (2006) Galectin-3 and Gal-1 bind distinct cell surface glycoprotein receptors to induce T cell death. J Immunol 176:778–789
Stitt AW, McGoldrick C, Rice-McCaldin A et al (2005) Impaired retinal angiogenesis in diabetes: role of advanced glycation end products and galectin-3. Diabetes 54:785–794
Stowell SR, Arthur CM, Mehta P et al (2008) Gal-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens. J Biol Chem 283:10109–10123
Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21:335–376
van den Berg TK, Honing H, Franke N et al (2004) LacdiNAc-glycans constitute a parasite pattern for galectin-3-mediated immune recognition. J Immunol 173:1902–1907
van Kimmenade RR, Januzzi JL Jr, Ellinor PT et al (2006) Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure. J Am Coll Cardiol 48:1217–1224
Vito P, Pellegrini L, Guiet C, D’Adamio L (1999) Cloning of AIP1, a novel protein that associates with the apoptosis-linked gene ALG-2 in a Ca2 + −dependent reaction. J Biol Chem 274:1533–1540
Vlassara H, Li YM, Imani F et al (1995) Identification of galectin 3 as a high affinity binding protein for advanced glycation end products (AGE): a new member of the AGEreceptor complex. Mol Med 1:634–646
Vray B, Camby I, Vercruysse V et al (2004) Up-regulation of galectin-3 and its ligands by Trypanosoma cruzi infection with modulation of adhesion and migration of murine dendritic cells. Glycobiology 14:647–657
Walzel H, Blach M, Hirabayashi J, Kasai KI, Brock J (2000) Involvement of CD2 and CD3 in galectin-1 induced signaling in human Jurkat T-cells. Glycobiology 10:131–140
Wang J, Barke RA, Charboneau R, Roy S (2005) Morphine impairs host innate immune response and increases susceptibility to Streptococcus pneumoniae lung infection. J Immunol 174:426–434
Wang JL, Gray RM, Haudek KC, Patterson RJ (2004) Nucleocytoplasmic lectins. Biochim Biophys Acta 1673:75–93
Wang W, Park JW et al (2006) Immunoprecipitation of spliceosomal RNAs by antisera to Gal-1 and galectin-3. Nucleic Acids Res 34:5166–5174
Weigert J, Neumeier M, Wanninger J et al (2010) Serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetes. J Clin Endocr Metab 9:1404–1411
Woldesenbet S, Garcia R, Igbo N et al (2004) Lectin receptors for endometrial H-type 1 antigen on goat conceptuses. Am J Reprod Immunol 52:74–80
Woo H-J, Shaw LM, Messier JM, Mercurio AM (1990) The major nonintegrin laminin binding protein of macrophages is identical to carbohydrate binding pro-tein 35 (Mac-2). J Biol Chem 265:7097–7099
Yang RY, Hsu DK, Liu FT (1996) Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci USA 93:6737–6742
Yoshii T, Fukumori T et al (2002) Galectin phosphorylation is required for its anti-apoptotic function and cell cycle arrest. J Biol Chem 277:6852–6857
Yu F, Finley RL Jr, Raz A, Kim H-RC (2002) Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. A role for synexin in galectin-3 translocation. J Biol Chem 277:15819–15827
Zhu W, Sano H, Nagai R et al (2001) The role of galectin-3 in endocytosis of advanced glycation end products and modified low density lipoproteins. Biochem Biophys Res Commun 280:1183–1188
Zlatkine P, Mehul B, Magee AI (1997) Retargeting of cytosolic proteins to the plasma membrane by the Lck protein tyrosine kinase dual acylation motif. J Cell Sci 110:673–679
Zörnig M, Hueber A-O, Baum W, Evan G (2001) Apoptosis regulators and their role in tumorigenesis. Biochim Biophys Acta 1551:F1–F37
Zuberi RI, Hsu DK, Kalayci O et al (2004) Critical role for galectin-3 in airway inflammation and bronchial hyperresponsiveness in a murine model of asthma. Am J Pathol 165:2045–2053
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Wien
About this chapter
Cite this chapter
Gupta, A. (2012). Galectin-3: Forms, Functions, and Clinical Manifestations. In: Animal Lectins: Form, Function and Clinical Applications. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1065-2_12
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1065-2_12
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1064-5
Online ISBN: 978-3-7091-1065-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)